CEO SUMMARY: AmeriPath’s Initial Public Offering will make it the first publicly traded physician practice management company specializing in pathology. It represents a unique attempt to restructure traditional pathology practices to meet the needs of managed healthcare organizations. PATHOLOGY ENTERS A NEW ERA when AmeriPath, Inc. completes its proposed Initial Public Offering (IPO) during the […]
To access this post, you must purchase The Dark Report.